000			04288nam a22004215i 4500
001			81447
003			ES-MaUEC
005			20230207040330.0
007			cr nn 008mamaa
008			150825s2015 gw | s |||| 0|eng d
020			_a9783319197791
024	7		_a10.1007/978-3-319-19779-1 _2doi
050		4	_aRE350 _b.A557 2015
245	1	0	_aAniridia : _bRecent Developments in Scientific and Clinical Research _cedited by Mohit Parekh, Barbara Poli, Stefano Ferrari, Corrado Teofili, Diego Ponzin.
250			_a1st ed. 2015.
260			_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (VIII, 192 páginas) _b57 ilustraciones, 54 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aPreface -- What is Aniridia: Epidemiology, clinical features and genetic implications -- Optical Coherence Tomography imaging in patients with PAX6 mutations -- Aniridic Glaucoma: Diagnosis and Treatment -- Management of Glaucoma in Congenital Aniridia -- Clinical and surgical management of cataract in congenital aniridia -- The ocular surface in aniridia -- Aniridic Keratopathy: Conservative approaches -- Lamellar and penetrating keratoplasty in congenital aniridia -- Boston KPRo Type I as a viable alternative to visual rehabilitation in aniridia patients: advances and limitations -- Cell therapy for regeneration of the corneal epithelium aniridic patients -- Strategies for success in limbal allograft transplantation for aniridia -- The paediatric patient: identifying congenital aniridia as soon as possible -- Early diagnosis: the key roles of neonatologists, paediatricians and paediatric ophthalmologists -- Aniridia guides and aniridia-syndrome (Pax6-Syndrome) -- Assessing the visual function in congenital aniridia and following the child during daily life -- Children with aniridia and healthcare systems: from needs assessment to a comprehensive programme of care and assistance -- European/international guidelines on Aniridia: the patientsâ€{u0C2F}int of view -- What to do when diagnosed with Aniridia: the role of patients ássociations -- Conclusions and future perspectives -- Index.
520	3		_aThe aim of this book is to highlight the latest findings in Aniridia research. Aniridia, meaning “without irisâ€{uC829}s a rare genetic disorder affecting vision, characterized by the incomplete formation of the iris (the coloured part of the eye that surrounds the black pupil). It may also cause other segments of the eye to be under-developed such as the optic nerve and the macula (the central part of the retina). Aniridia and associated conditions affect individuals differently. So while some affected people are partially sighted or blind, others may have near normal sight. Aniridia is congenital (present at birth) and is caused by a dysfunction of the PAX6 gene, situated on the 11th chromosome that causes the premature cessation of eye development. Aniridia affects between 1:40,000 to 1:100,000 people, and affects males and females equally. People with Aniridia may also experience secondary conditions such as Photophobia, Nystagmus, Glaucoma, Cataracts and Keratopathy.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
988			_aEBOOK, EBSPRINGER, asignarmaterias_11febrero
650		7	_aCitología _0 _2embne _9139477
650	2	7	_aCiencias biomédicas _0 _2embne _9143729
650		7	_aOftalmología _0 _2embne _9139186
700	1		_aParekh, Mohit _eeditor literario _993878 _0Local
700	1		_aPoli, Barbara _eeditor literario _993879 _0Local
700	1		_aFerrari, Stefano _eeditor literario _993880 _0Local
700	1		_aTeofili, Corrado _eeditor literario _993881 _0Local
700	1		_aPonzin, Diego _eeditor literario _993882 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-19779-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12900370 _b10-10-17 _c18-01-16
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRE350 .A557 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11569992 _z06-04-17
999			_c81447 _d81447 _x1